| Literature DB >> 27723842 |
Shin Ahn1, Hyeji Lee2, Wookjin Choi2, Ryeok Ahn2, Jung-Suk Hong2, Chang Hwan Sohn1, Dong Woo Seo1, Yoon-Seon Lee1, Kyung Soo Lim1, Won Young Kim1.
Abstract
OBJECTIVE: We tried to evaluate the accuracy of the heel drop test in patients with suspected appendicitis and tried to develop a new clinical score, which incorporates the heel drop test and other parameters, for the diagnosis of this condition.Entities:
Mesh:
Year: 2016 PMID: 27723842 PMCID: PMC5056713 DOI: 10.1371/journal.pone.0164574
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical data for the study population.
| Features (n, %) | All (n = 292) | Acute appendicitis (n = 165) | Non-appendicitis (n = 127) | P |
|---|---|---|---|---|
| Age | 37.2 ± 15.6 | 39.1 ± 16.4 | 34.7 ± 14.1 | 0.015 |
| Male gender | 124 (42.5) | 81 (49.1) | 43 (33.9) | 0.009 |
| BT (°C) | 36.9 ± 0.7 | 36.9 ± 0.7 | 36.8 ± 0.6 | 0.199 |
| Symptoms | ||||
| Anorexia | 101 (34.6) | 60 (36.4) | 41 (32.3) | 0.467 |
| Nausea or vomiting | 138 (47.3) | 86 (52.1) | 52 (40.9) | 0.058 |
| Migration | 109 (37.3) | 80 (48.5) | 29 (22.8) | <0.001 |
| Laboratory finding | ||||
| WBC (x103/μL) | 11.2 (8.1–14.7) | 13.1 (10.4–16.1) | 8.6 (6.7–11.9) | <0.001 |
| Neutrophil (%) | 77.1 (67.4–83.6) | 80.0 (73.0–84.8) | 71.2 (59.9–81.4) | <0.001 |
| C-reactive protein (mg/dL) | 0.6 (0.1–3.2) | 1.0 (0.2–3.9) | 0.4 (0.1–2.6) | 0.002 |
| Physical examination | ||||
| Rebound tenderness | 144 (49.3) | 97 (58.8) | 47 (37.0) | <0.001 |
| Defense | 71 (24.3) | 47 (28.5) | 24 (18.9) | 0.058 |
| Psoas | 88 (30.1) | 59 (35.8) | 29 (22.8) | 0.017 |
| Rovsing | 61 (20.9) | 42 (25.5) | 19 (15.0) | 0.029 |
| Obturator | 70 (24.0) | 46 (27.9) | 24 (18.9) | 0.075 |
| Heel drop | 159 (54.5) | 114 (69.1) | 45 (35.4) | <0.001 |
*mean (standard deviation),
**median (interquartile range).
BT body temperature; WBC white blood cell.
Features of the Alvarado score and heel drop test in assessing acute appendicitis.
| Features (n, %) | Uncomplicated appendicitis (n = 122) | Complicated appendicitis (n = 43) | P |
|---|---|---|---|
| Anorexia | 48 (39.3) | 12 (27.9) | 0.180 |
| Nausea or vomiting | 69 (56.6) | 17 (39.5) | 0.055 |
| Migration | 56 (45.9) | 24 (55.8) | 0.263 |
| Rebound tenderness | 69 (56.6) | 28 (65.1) | 0.327 |
| BT≥37.3°C | 24 (19.7) | 14 (32.6) | 0.084 |
| WBC>10,000/μL | 93 (76.2) | 33 (76.7) | 0.946 |
| Shift to left | 84 (68.9) | 31 (72.1) | 0.691 |
| Heel drop | 81 (66.4) | 33 (76.7) | 0.207 |
BT body temperature; WBC white blood cell.
Development of the MESH score.
| Variable | OR (95% CI) | Point |
|---|---|---|
| Migration | 2.44 (1.36–4.38) | 2 |
| Heel Drop | 3.43 (1.98–5.93) | 3 |
| WBC>10,000/μL | 3.38 (1.87–6.14) | 3 |
| Shift to left | 2.35 (1.30–4.25) | 2 |
| Total | 10 |
MESH Migration, Elevated WBC, Shift to left, and Heel drop test; OR odds ratio; CI confidence interval; WBC white blood cell.
Fig 1Receiver operating characteristic (ROC) curve analysis for the MESH score and the Alvarado score.
MESH Migration, Elevated WBC, Shift to left, and Heel drop test; AUC area under ROC curve; CI confidence interval.
Fig 2Box plot displaying the distribution of the MESH score in patients with a normal appendix, uncomplicated appendicitis, and perforated appendicitis (cutoff of 5).
MESH Migration, Elevated WBC, Shift to left, and Heel drop test.
Performance of the parameters included in the Alvarado score, heel drop test, calculated MESH score, and the Alvarado score*.
| Sensitivity | Specificity | PPV | NPV | PLR | NLR | |
|---|---|---|---|---|---|---|
| Migration | 0.48 (0.41–0.56) | 0.77 (0.68–0.84) | 0.73 (0.64–0.81) | 0.53 (0.46–0.60) | 2.11 (1.48–3.00) | 0.67 (0.57–0.78) |
| Anorexia | 0.36 (0.29–0.44) | 0.67 (0.59–0.76) | 0.59 (0.49–0.69) | 0.45 (0.38–0.52) | 1.13 (0.82–1.56) | 0.94 (0.83–1.06) |
| Nausea/vomiting | 0.52 (0.44–0.60) | 0.59 (0.50–0.68) | 0.62 (0.54–0.70) | 0.49 (0.41–0.57) | 1.27 (0.99–1.64) | 0.81 (0.68–0.96) |
| WBC>10,000 | 0.76 (0.69–0.82) | 0.64 (0.55–0.72) | 0.73 (0.66–0.80) | 0.68 (0.52–0.76) | 2.11 (1.65–2.70) | 0.39 (0.28–0.49) |
| Shift to left | 0.70 (0.62–0.76) | 0.62 (0.53–0.71) | 0.71 (0.63–0.77) | 0.61 (0.52–0.70) | 1.84 (1.44–2.36) | 0.49 (0.38–0.62) |
| BT≥37.3°C | 0.23 (0.17–0.30) | 0.80 (0.71–0.86) | 0.59 (0.46–0.71) | 0.44 (0.38–0.51) | 1.12 (0.72–1.75) | 0.97 (0.89–1.05) |
| Rebound tenderness | 0.59 (0.51–0.66) | 0.63 (0.54–0.71) | 0.67 (0.59–0.75) | 0.54 (0.46–0.62) | 1.59 (1.22–2.06) | 0.65 (0.54–0.79) |
| Heel drop | 0.69 (0.61–0.76) | 0.65 (0.56–0.73) | 0.72 (0.64–0.78) | 0.62 (0.53–0.70) | 1.95 (1.51–2.52) | 0.48 (0.38–0.61) |
| MESH score ≥5 | 0.86 (0.80–0.91) | 0.60 (0.50–0.68) | 0.73 (0.66–0.79) | 0.77 (0.67–0.84) | 2.10 (1.69–2.61) | 0.24 (0.16–0.35) |
| MESH score ≥8 | 0.52 (0.44–0.59) | 0.91 (0.84–0.95) | 0.88 (0.79–0.93) | 0.59 (0.52–0.66) | 5.45 (3.12–9.53) | 0.54 (0.46–0.63) |
| Alvarado ≥5 | 0.75 (0.67–0.81) | 0.50 (0.41–0.59) | 0.65 (0.58–0.72) | 0.62 (0.52–0.71) | 1.50 (1.24–1.82) | 0.50 (0.38–0.66) |
| Alvarado ≥7 | 0.37 (0.30–0.45 | 0.87 (0.80–0.92) | 0.79 (0.68–0.87) | 0.52 (0.45–0.58) | 2.93 (1.78–4.84) | 0.72 (0.64–0.81) |
*data are presented with a 95% confidence interval.
MESH Migration, Elevated WBC, Shift to left, and Heel drop test; PPV positive predictive value; NPV negative predictive value; PLR positive likelihood ratio; NLR negative likelihood ratio.
Performance of the MESH score and the Alvarado score according to gender*.
| Sensitivity | Specificity | PPV | NPV | PLR | NLR | ||
|---|---|---|---|---|---|---|---|
| MESH score ≥5 | Male | 0.90 (0.81–0.95) | 0.49 (0.34–0.64) | 0.77 (0.67–0.85) | 0.72 (0.53–0.87) | 1.76 (1.30–2.38) | 0.27 (0.10–0.41) |
| Female | 0.82 (0.72–0.89) | 0.64 (0.53–0.74) | 0.70 (0.60–0.78) | 0.78 (0.66–0.87) | 2.30 (1.70–3.12) | 0.28 (0.17–0.45) | |
| MESH score ≥8 | Male | 0.52 (0.41–0.63) | 0.88 (0.74–0.96) | 0.89 (0.76–0.96) | 0.49 (0.38–0.61) | 4.46 (1.91–10.44) | 0.54 (0.43–0.69) |
| Female | 0.45 (0.34–0.56) | 0.92 (0.83–0.96) | 0.84 (0.70–0.93) | 0.63 (0.53–0.71) | 5.43 (2.57–11.46) | 0.59 (0.49–0.73) | |
| MESH ≥5 | Male | 0.71 (0.60–0.80) | 0.48 (0.33–0.64) | 0.72 (0.61–0.81) | 0.47 (0.32–0.63) | 1.39 (1.01–1.93) | 0.58 (0.39–0.86) |
| Female | 0.78 (0.68–0.86) | 0.53 (0.42–0.64) | 0.63 (0.53–0.72) | 0.71 (0.58–0.81) | 1.69 (1.31–2.18) | 0.40 (0.26–0.61) | |
| MESH ≥7 | Male | 0.32 (0.22–0.43) | 0.83 (0.68–0.92) | 0.78 (0.60–0.90) | 0.39 (0.29–0.50) | 1.97 (0.93–4.16) | 0.81 (0.69–0.95) |
| Female | 0.42 (0.31–0.53) | 0.89 (0.80–0.95) | 0.79 (0.64–0.89) | 0.60 (0.51–0.69) | 3.88 (1.99–7.58) | 0.65 (0.54–0.78) |
*data are presented with 95% confidence interval.
MESH Migration, Elevated WBC, Shift to left, and Heel drop test; PPV positive predictive value; NPV negative predictive value; PLR positive likelihood ratio; NLR negative likelihood ratio.